Evidence map›Paper›PMID 40416450›Full record

ReviewIndian journal of endocrinology and metabolism

Immune Reconstitution Inflammatory Syndrome Following Remission of Cushing's Syndrome and Review of Literature.

Mintu M Baruah, Umanath Adhikari, Trupti Prasad, Biona D Konsam, Liza Das, Aman Sharma, Sanjay K Bhadada, Rama Walia

Abstract readReview
In one paragraph

Review in Indian journal of endocrinology and metabolism. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mintu M BaruahDepartment of Endocrinology, PGIMER, Chandigarh, India.
Umanath AdhikariDepartment of Endocrinology, PGIMER, Chandigarh, India.
Trupti PrasadDepartment of Endocrinology, PGIMER, Chandigarh, India.
Biona D KonsamDepartment of Endocrinology, PGIMER, Chandigarh, India.
Liza DasDepartment of Endocrinology, PGIMER, Chandigarh, India.
Aman SharmaDepartment of Clinical Immunology and Rheumatology, PGIMER, Chandigarh, India.
Sanjay K BhadadaDepartment of Endocrinology, PGIMER, Chandigarh, India.
Rama WaliaDepartment of Endocrinology, PGIMER, Chandigarh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current study aims to report cases of immune reconstitution inflammatory syndrome (IRIS) following Cushing's syndrome (CS) treatment and elucidate various presentations of IRIS and its management. A single-centre study was conducted in individuals with endogenous CS who presented with immune reconstitution inflammatory syndrome after CS remission. A literature review was also conducted to describe the previous reporting of IRIS. Nine cases from the author's centre were identified. Out of 9 cases, one case was ectopic CS, who presented with CNS vasculitis following excision of the primary lesion. Other 8 cases were Cushing's disease (CD) presented with diverse IRIS manifestations in the form of thyroiditis, oculomotor neuritis, extraocular muscle palsy, episcleritis, bell's palsy, rheumatoid arthritis (RA) and Charcot neuroarthropathy, with the time of presentation from less than 1 month till 24 months. The most common IRIS described in the literature is thyroid dysfunction, and the time of presentation of IRIS is variable from less than one month to 5 years. Immune reconstitution inflammatory syndrome is a unique and rare post-operative complication after CS remission, affecting various organ systems due to rebound immunity.

Indexed as

Autoimmune dysfunctionCushing’s syndromeimmune reconstitution inflammatory syndrome

Identifiers

PMID40416450
PMCPMC12101748

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.